Market Data 
Markets
Replies to post #18875 on The Rising Influence of Rising Affluence
06/04/19 10:03 AM
Under the terms of the Bayer Collaboration Agreement, the Company will receive an aggregate upfront payment of $17.5 million within 30 days of the Effective Date. The Company is entitled to receive up to an additional $12.0 million in research funding payments, subject to increases, as described above. The Company is also eligible to receive up to $197.5 million in development milestones and up to $490.0 million in sales-based milestones for all designated Targets. In addition, the Company is eligible to receive, on net sales of PROTAC targeted protein degrader-related products, mid-single digit to low-double digit tiered royalties, which may be subject to reductions.
…In connection with the execution of the Bayer Collaboration Agreement and the Commitment Agreement, Bayer and the Registrant also entered into a stock purchase agreement (the “Stock Purchase Agreement”) on June 3, 2019 (the “Signing Date”) for the sale and issuance of 1,346,313 shares of common stock (the “Shares”) to Bayer at a price of $24.14 per share, for an aggregate purchase price of approximately $32.5 million.
AI
